Correlation Study of Urinary Angiotensinogen and Renal Interstitial Inflammatory Cell Infiltration
1.Department of Nephrology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China
2.Institute of Nephrology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China
*Corresponding author:LIU Dong,Associate professor,Associate chief physician;E-mail:liudong030@163.com
[1]HEALY E,BRADY H R.Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease[J].Curr Opin Nephrol Hypertens,1998,7(5):525-530.
[2]MISE K,HOSHINO J,UENO T,et al.Prognostic value of tubulointerstitial lesions,urinary N-Acetyl-beta-d-Glucosaminidase,and urinary beta2-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy[J].Clin J Am Soc Nephrol,2016,11(4):593-601.DOI:10.2215/CJN.04980515.
[3]LIU Y.Cellular and molecular mechanisms of renal fibrosis[J].Nat Rev Nephrol,2011,7(12):684-696.DOI:10.1038/nrneph.2011.149.
[4]GRANDE M T,PRERZ-BARRIOCANAL F,LOPEZ-NOVOA J M.Role of inflammation in tubulo-interstitial damage associated to obstructive nephropathy[J].J Inflamm (Lond),2010,7:19.DOI:10.1186/1476-9255-7-19.
[5]KOBORI H,NANGAKU M,NAVAR L G,et al.The intrarenal renin-angiotensin system:from physiology to the pathobiology of hypertension and kidney disease[J].Pharmacol Rev,2007,59(3):251-287.DOI:10.1124/pr.59.3.3.
[6]ROHRWASSER A,MORGAN T,DILLON H F,et al.Elements of a paracrine tubular renin-angiotensin system along the entire nephron[J].Hypertension,1999,34(6):1265-1274.
[7]KOBOR H,NISHIYAMA A,HARRISON-BERNARD L M,et al.Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension[J].Hypertension,2003,41(1):42-49.
[8]KOBORI H,HARRISON-BERNARD L M,NAVAR L G.Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production[J].Kidney Int,2002,61(2):579-585.DOI:10.1046/j.1523-1755.2002.00155.x.
[9]YAMAMOTO T,NAKAGAWA T,SUZUKI H,et al.Urinary angiotensinogen as a marker of intrarenal angiotensinⅡ activity associated with deterioration of renal function in patients with chronic kidney disease[J].J Am Soc Nephrol,2007,18(5):1558-1565.DOI:10.1681/ASN.2006060554.
[10]LAI K N,LEUNG J C,LAI K B,et al.Gene expression of the renin-angiotensin system in human kidney[J].J Hypertens,1998,16(1):91-102.
[11]LEVEY A S,STEVENS L A,SCHMID C H,et al.A new equation to estimate glomerular filtration rate[J].Ann Intern Med,2009,150(9):604-612.
[12]KATAFUCHI R,KIYOSHI Y,OH Y,et al.Glomerular score as a prognosticator in IgA nephropathy:its usefulness and limitation[J].Clin Nephrol,1998,49(1):1-8.
[13]KATSURADA A,HAGIWARA Y,MIYASHITA K,et al.Novel sandwich ELISA for human angiotensinogen[J].Am J Physiol Renal Physiol,2007,293(3):F956-960.DOI:10.1152/ajprenal.00090.2007.
[14]SUZAKI Y,OZAWA Y,KOBORI H.Quantification of human angiotensinogen by a novel sandwich ELISA[J].Peptides,2006,27(11):3000-3002.DOI:10.1016/j.peptides.2006.05.006.
[15]REBHOLZ C M,CHEN J,ZHAO Q,et al.Urine angiotensinogen and salt-sensitivity and potassium-sensitivity of blood pressure[J].J Hypertens,2015,33(7):1394-1400.DOI:10.1097/HJH.0000000000000564.
[16]SAWAGUCHI M,ARAKI S I,KOBORI H,et al.Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus[J].J Diabetes Investig,2012,3(3):318-324.DOI:10.1111/j.2040-1124.2011.00172.x.
[17]SATIRAPOJ B,SIRITAWEESUK N,SUPASYNDH O.Urinary angiotensinogen as a potential biomarker of diabetic nephropathy[J].Clin Kidney J,2014,7(4):354-360.DOI:10.1093/ckj/sfu059.
[18]URUSHIHARA M,NAGAI T,KINOSHITA Y,et al.Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients[J].Pediatr Nephrol,2015,30(6):975-982.DOI:10.1007/s00467-014-3028-8.
[19]章晓燕.尿血管紧张素原与肾脏局部肾素—血管紧张素系统活性关系的研究[D].上海:复旦大学,2009.
[20]MEZZANO S A,AROS C A,DROGUETT A,et al.Renal angiotensin Ⅱup-regulation and myofibroblast activation in human membranous nephropathy[J].Kidney Int Suppl,2003(86):S39-45.
[21]章晓燕,吕文律,滕杰,等.慢性肾脏病患者尿血管紧张素原与肾脏肾素血管紧张素系统活性的相关性[J].中华肾脏病杂志,2011,27(5):327-332.DOI:10.3760/cma.j.issn.1001-7097.2011.05.005.
[22]KOBORI H,OHASHI N,KATSURADA A,et al.Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases[J].J Am Soc Hypertens,2008,2(5):349-354.DOI:10.1016/j.jash.2008.04.008.
[23]ALGE J L,KARAKALA N,NEELY B A,et al.Association of elevated urinary concentration of renin-angiotensin system components and severe AKI[J].Clin J Am Soc Nephrol,2013,8(12):2043-2052.DOI:10.2215/CJN.03510413.
[24]ALGE J L,KARAKALA N,NEEELY B A,et al.Urinary angiotensinogen and risk of severe AKI[J].Clin J Am Soc Nephrol,2013,8(2):184-193.DOI:10.2215/CJN.06280612.
[25]KOBORI H,NISHIYAMA A.Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats[J].Biochem Biophys Res Commun,2004,315(3):746-750.DOI:10.1016/j.bbrc.2004.01.120.
[26]RUIZ-ORTEGA M,RUPEREZ M,LORENZO O,et al.Angiotensin Ⅱ regulates the synthesis of proinflammatory cytokines and chemokines in the kidney[J].Kidney Int Suppl,2002(82):S12-22.DOI:10.1046/j.1523-1755.62.s82.4.x.
[27]ZHUO J L.Monocyte chemoattractant protein-1:a key mediator of angiotensinⅡ-induced target organ damage in hypertensive heart disease?[J].J Hypertens,2004,22(3):451-454.DOI:10.1097/01.hjh.0000098211.37783.e7.
[28]WU Y,YANG L,SU T,et al.Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis[J].Clin J Am Soc Nephrol,2010,5(11):1954-1959.DOI:10.2215/CJN.02370310.